Skip to main content

Table 1 Scoring system used to document cutaneous and subcutaneous reactions in breast cancer patients receiving radiotherapy

From: Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes

Grade

Early reactionsa

Late reactionsb

Grade 0 – Highly radioresistant patients

No toxicity observed: no erythema, desquamation, or pain

Absence of differences between irradiated and nonirradiated skin

Grade 1 – Moderately radioresistant patients

Faint, dull, or bright erythema, psilosis, dry desquamation, mild oedema

Minimal telangiectasia, slight breast asymmetry, mild hyperpigmentation

Grade 2 – Patients with average radiosensitivity

Severe erythema, at least one moist desquamation of small size, moderate oedema

Marked telangiectasia, moderate hyperpigmentation, increased density and palpable firmness, mild oedema

Grade 3 – Moderately radiosensitive patients

Severe or confluent moist desquamation

Partially confluent telangiectasia, severe hyperpigmentation, severe oedema, subcutaneous fibrosis with fixation

Grade 4 – Highly radiosensitive patients

Ulceration, haemorrhage

Totally confluent telangiectasia, very marked density, retraction and fixation. Major aesthetic sequelae in treated breast

  1. aMorbidity assessed at the end of radiotherapy treatment. bMorbidity assessed at end of 7-year follow-up period